Psychedelics proven to reduce depression. Clinical trial shows 100% of participants responsive to treatment, 71% in remission after 12 months and only 2 doses.
Extraordinary demand for RSV monoclonal antibody shot has resulted in shortages. Yesterday, the CDC released an additional 77,000 doses to safeguard infants against the respiratory infection.